Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
2.600
-0.020 (-0.76%)
At close: Jun 29, 2026, 4:00 PM EDT
2.600
0.00 (0.00%)
Pre-market: Jun 30, 2026, 4:04 AM EDT
Anavex Life Sciences Employees
Anavex Life Sciences had 34 employees as of September 30, 2025. The number of employees decreased by 8 or -19.05% compared to the previous year.
Employees
34
Change (1Y)
-8
Growth (1Y)
-19.05%
Revenue / Employee
n/a
Profits / Employee
-$1,174,912
Market Cap
240.95M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 34 | -8 | -19.05% |
| Sep 30, 2024 | 42 | 2 | 5.00% |
| Sep 30, 2023 | 40 | 2 | 5.26% |
| Sep 30, 2022 | 38 | 13 | 52.00% |
| Sep 30, 2021 | 25 | 5 | 25.00% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Karyopharm Therapeutics | 228 |
| Fate Therapeutics | 161 |
| Coherus Oncology | 145 |
| Nautilus Biotechnology | 127 |
| AC Immune | 122 |
| Foghorn Therapeutics | 106 |
| Orchestra BioMed Holdings | 86 |
| Fulcrum Therapeutics | 55 |
AVXL News
- 5 weeks ago - Anavex receives expected Nasdaq delinquency notification - TheFly
- 5 weeks ago - Anavex Life Sciences Receives Expected Nasdaq Delinquency Notification - GlobeNewsWire
- 7 weeks ago - Anavex delays 10Q filing - TheFly
- 7 weeks ago - Anavex Life Sciences names Terrie Kellmeyer interim CEO, succeeding Missling - TheFly
- 7 weeks ago - Anavex Life Sciences Board of Directors Appoints Former Senior Vice President of Clinical Development Terrie Kellmeyer, PhD, as Interim Chief Executive Officer - GlobeNewsWire
- 2 months ago - Anavex initiated with a Buy at Rodman & Renshaw - TheFly
- 2 months ago - Anavex Life Sciences Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 2 months ago - Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer's Disease - GlobeNewsWire